1. Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by the monoamine oxidase inhibitors pargyline and nialamide;Heikkila;Nature,1984
2. Citalopram - pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity;Hyttel;Prog. Neurol. Psychopharm. Biol. Psych.,1982
3. Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: characterization and localization of receptor binding sites in rat and human brain;Javitch,1984
4. Intraneuronal generation of a pyridinium metabolite may cause drug-induced Parkinsonism;Markey;Nature,1984
5. High affinity binding sites for [3H]MPTP may correspond to monoamine oxidase;Parsons;European J. Pharmacol.,1984